Sirolimus-tacrolimus combination immunosuppression.

Lancet · 2000

case_series · Level IV

Where this comes from

Abstract

A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.